Journal of Investigative Medicine (JIM) is a multi-disciplinary journal dedicated to publishing high-quality original research and reviews. The journal aims to provide rapid publication of research through its continuous online publication model. Submissions should be made through the journal’s new online submission system. All submissions are subject to peer review. Articles should not be under review or under consideration by any other journal when submitted to Journal of Investigative Medicine.
Journal of Investigative Medicine is a member journal of the Committee on Publication Ethics (COPE) and is a sponsor of the Equator Network, which is an international initiative that promotes transparent, accurate reporting of research studies.
Journal of Investigative Medicine adheres to the highest standards concerning its editorial policies on publication ethics, scientific misconduct, consent and peer review criteria. To view all BMJ Journal policies please refer to the BMJ Author Hub policies page.
Articles are published under an exclusive licence (or non-exclusive licence for UK Crown and US Federal Government employees) and authors retain copyright. Articles can also be published under a Creative Commons licence to facilitate reuse of the content; please refer to the Journal of Investigative Medicine Copyright Author Licence Statement.
Journal of Investigative Medicine adheres to BMJ’s Tier 3 data policy. We strongly encourage that data generated by your research that supports your article be made available as soon as possible, wherever legally and ethically possible. All research articles must contain a Data Availability Statement. For more information and FAQs, please see BMJ’s full Data Sharing Policy page.
Journal of Investigative Medicine mandates ORCID iDs for the submitting author at the time of article submission; co-authors and reviewers are strongly encouraged to also connect their ScholarOne accounts to ORCID. We strongly believe that the increased use and integration of ORCID iDs will be beneficial for the whole research community.
Please find more information about ORCID and BMJ’s policy on our Author Hub.
Article publishing charges (APC)
During submission, authors can choose to have their article published open access for USD $2,000 for a CC-BY-NC license or USD $2,580 for those funders who require a license that requires a CC-BY license.
For more information on open access, funder compliance and institutional programmes please refer to the BMJ Author Hub open access page.
Does Journal of Investigative Medicine offer discounts and waivers on the APC?
Which funding agencies allow direct use of grants to cover the APC?
If you received a grant to conduct your research, your first enquiry should be to whoever disburses the research funds. Much research funding is now granted on the condition that any resulting articles are published Open Access and are deposited in PubMed Central – publishing in Journal of Investigative Medicine means that you meet both of these criteria. To help authors complete these requirements, many funders will permit payment of APCs from grants or have separate funds available.
The Open Access Directory contains a list of universities that have funds for researchers to pay APCs. The Scholarly Publishing and Academic Resources Coalition (SPARC) has something similar – both mainly cover US institutions and are not comprehensive. The Compact for Open Access Publishing Equity is a collection of universities that have pledged their support to establish durable mechanisms for underwriting the APC model. Alternatively, contact your librarian to find out what support your institution offers.
General information about BMJ’s Open Access program, including copyright policies and institutional memberships, is available via our author website.
Journal of Investigative Medicine charges $40/printed page unless the author is a verified American Federation for Medical Research (AFMR) member at the time of submission. In addition, a color publication charge of $400 will be levied for any color printing requested (color images are free online, but the author must provide two files per figure if they do not want to be charged for color printing).
Please review the below article type specifications including the required article lengths, illustrations, table limits and reference counts. The word count excludes the title page, abstract, tables, acknowledgements, contributions and references. Manuscripts should be as succinct as possible.
For further support when making your submission please refer to the resources available on the BMJ Author Hub. Here you can also find general formatting guidelines across BMJ and a formatting checklist. You may also wish to use the language editing and translation services provided by BMJ Author Services.
If your article is accepted you can take advantage of BMJ’s partnership with Kudos, a free service to help you maximise your article’s reach.
Review articles are expected to be comprehensive, scholarly, and balanced, presenting an expert curation of the literature on the topic of interest.
Generally, reviews are limited to: 250-word abstract; 4,000-word text, excluding references; and 5 figures. Authors are encouraged to consult the Editor before submitting a review for consideration.
Research Tools and Issues
Research Tools and Issues are scholarly works and reviews focusing on areas of broad interest to the research community, including topics relevant to the conduct of clinical research, mentoring, and career development.
Manuscripts should not exceed 4,000 words.
Original articles should not exceed 5,000 words and 6 figures or tables (not including supplementary material) — articles must be fully documented reports of original research, but should be as concise as possible without compromising the data.
Articles should be organized as follows: Title page, Unstructured Abstract (250 words max), Introduction, Materials & Methods, Results, Discussion, Conflict of Interest, Acknowledgments, References, Tables, Figure Legends, Supplementary Material.
EB Symposium Manuscripts
The AFMR sponsors one or more symposia each year within the context of the Experimental Biology meeting. These symposia are translational in focus and are designed to highlight important recent basic science developments that are being brought to the bedside. It is anticipated that each presenter within each symposium will submit a manuscript to Journal of Investigative Medicine that summarizes the work described in their symposium talk.
Each manuscript should be self-contained, as the publication may not be coordinated with the publication of other manuscripts from the same symposium. The presenters are encouraged to present sufficient background and detail to permit a full appreciation of the importance and implications of their work. It is anticipated that most EB Symposium manuscripts will be 2000-6000 words in length. The liberal use of figures and diagrams is encouraged.
These reports should be of scientific excellence in clinical or translational research, but not sufficient to warrant publication as Original Research. Examples of appropriate Brief Reports may include: (1) studies that report limited but provocative observations OR (2) relevant negative studies that can
provide new information on important topics.
The text of a Brief Report is limited to 2,000 words. Brief Reports should include an abstract of no more than 250 words and no more than 2 display items.
Letter to the Editor (e-only)
Letters to the Editor may report original data or discuss published articles in Journal of Investigative Medicine.
Letters are not to exceed 1,000 words, 2 figures or tables, and 15 references. Letters should not have an abstract. The Editor may solicit a response from the authors. Letters that report original data will be fully peer-reviewed. All Letters to the Editor are subject to editing and possible abridgment.
Journal of Investigative Medicine will consider publishing supplements to regular issues. Supplement proposals should be submitted to the Editorial Office.